Floatz logo

VARINON

Digital Ulcer

Primus PharmaceuticalsSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Digital Ulcer cohort.

Asset / SponsorPhaseRating
Bosentan
Elpen Pharmaceutical Co. Inc.
D

Same molecule, other indications

VARINON is also rated in:

post-operative wound seroma, non-human animalDormant
BB
Indicative ·
69 / 100
View asset →
breast cancerDormant
BB
Indicative ·
68 / 100
View asset →
chronic venous insufficiencyDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →